Prostatakarzinom

StudieTherapieformRekrutierungSubinvestigator
PRIAS
Prostate Cancer Research International - active surveillance
NAoffenArsov/ Giessing/ Albers
PROMM-AS
Prospective Multicenter Phase II Trial evaluating Multiparametric MRI; Radiomics, MR-guided Biopsy and Molecular Markers for Active Surveillance of Patients with Low- and Intermediate Risk Prostate Cancer
Active SurveillanceoffenArsov/ Albers/ Schimmöller

SAKK 96/12
Prevention of Symptomatic Skeletal Events with Denosumab Administered every 4 Weeks versus every 12 Weeks - A Non-Inferiority Phase III Trial

1st lineoffenAlbers/ Lorch/ Hiester

MR Pro-Active
Multiparametrisches MRT zur aktiven Überwachung von Patienten mit Low-Risk Prostata-Ca: eine prospektive, longitudinale, multizentrische Vergleichsstudie

Diagnostikin Vorbereitung (Start Dez. 2018)Arsov/ Albers/ Schimmöller
MediathekInformation und Wissen
LageplanSo finden Sie uns